Birdwatch Note Rating
2024-01-28 16:45:49 UTC - HELPFUL
Rated by Participant: 2E1E23C14EA7C71A94FB83DCF6493E31638860FA5C7E51E9420AE7597A2C8FD5
Participant Details
Original Note:
Of a total of 64 outcomes in studies of GET, NICE graded 52 (81%) as “VERY LOW” quality and 12 (19%) as “LOW” quality. It has been established that GET is not a suitable treatment for MECFS, and a significant cohort of Long Covid patients meet MECFS diagnostic criteria. https://www.nice.org.uk/guidance/gid-ng10091/documents/evidence-review-7
All Note Details